A Transparency Market Research report forecasts that the worldwide market for drug-device combination products such as drug-eluting stents, bone grafts and infusion pumps will increase from $66 billion in 2012 to $115.1 billion by 2019. Growth will be driven in part by the rising number of chronic obstructive pulmonary disease, asthma and cardiovascular disease cases, the report notes.

Related Summaries